Meet Dr. Oliver Bohnsack

Vice President, Scientific & Medical Services, Head of Oncology

Areas of Expertise

Oncology

Immunotherapy

Dr. Bohnsack is a recognized thought leader in oncology trial imaging, especially regarding the use of standardized review criteria and imaging based endpoints with a more recent focus on immune-oncology.

Key Achievements

40+ years of clinical trial imaging experience

Led and managed the imaging components of more than 800 oncology clinical trials

Supported with his contributions the approval of 25+ oncology medications.

Key Speaking Engagements & Publications

Co-author of the immune-related response criteria (irRC, 2009)

First author of irRECIST (2014)

Co-author of Comparison of Assessments using RECIST 1.1 and irRECIST and association with overall survival by Manitz J, Eggleton P. et al. (JITC 2022).